The WT1 Wilms' tumor suppressor gene: How much do we really know?
- 16 May 1996
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1287 (1), 1-28
- https://doi.org/10.1016/0304-419x(95)00014-7
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- GATA-1 Transactivates the WT1 Hematopoietic Specific EnhancerJournal of Biological Chemistry, 1995
- Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumourNature Genetics, 1994
- Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1The Journal of Pediatrics, 1993
- Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumourNature, 1993
- Effects of an Rb mutation in the mouseNature, 1992
- Transient expression of syndecan in mesenchymal cell aggregates of the embryonic kidneyDevelopmental Biology, 1992
- Constitutional mutations in the WT1 gene in patients with Denys-Drash syndromeHuman Molecular Genetics, 1992
- The distal region of 11p13 and associated genetic diseasesGenomics, 1991
- Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome)The Journal of Pediatrics, 1990
- Production of platelet‐derived growth factor by cultured Wilms' tumor cells and fetal kidney cellsJournal of Cellular Physiology, 1987